Bank of America’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-2,000
Closed -$87K 7411
2017
Q4
$87K Sell
2,000
-25,000
-93% -$1.17M ﹤0.01% 5807
2017
Q3
$1.41M Buy
+27,000
New +$1.51M ﹤0.01% 4269

Other funds holding SYNH

Bank of America's SYNH Position: Q3 2023 in Review

Bank of America sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 503,676 shares — an estimated $21.2M sold.

Bank of America first reported a position in SYNH in Q1 2015 and held it in 34 quarters. The position peaked at $129M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Bank of America reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bank of America sold 503,676 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $21.2M.
  • Bank of America first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2015 and held it in 34 quarters.
  • Bank of America's Syneos Health, Inc. Class A Common Stock position peaked at $129M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.